APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Generic Nifedipine Controlled-release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Generic Nifedipine Controlled-release Tablets Market Outlook and Growth Opportunities 2026

Report ID 173994790429 December 2025198 pages

Choose your research edition.

Industry ResearchGeneric Nifedipine Controlled-release Tablets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Generic Nifedipine Controlled-release Tablets Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Generic Nifedipine Controlled-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Generic Nifedipine Controlled-release Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Generic Nifedipine Controlled-release Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Generic Nifedipine Controlled-release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Generic Nifedipine Controlled-release Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Generic Nifedipine Controlled-release Tablets market include Simcere, Shanghai Shyndec Pharma, Qingdao Baiyang Pharmaceutical, Hefei Cube Pharma, Nanjing Easeheal Pharma, Deyao Pharma, CR DOUBLE-CRANE, Beijing Honglin Pharma and Apichope, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Generic Nifedipine Controlled-release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Generic Nifedipine Controlled-release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Generic Nifedipine Controlled-release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Generic Nifedipine Controlled-release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Generic Nifedipine Controlled-release Tablets Segment by Company

Simcere

Shanghai Shyndec Pharma

Qingdao Baiyang Pharmaceutical

Hefei Cube Pharma

Nanjing Easeheal Pharma

Deyao Pharma

CR DOUBLE-CRANE

Beijing Honglin Pharma

Apichope

Generic Nifedipine Controlled-release Tablets Segment by Type

30mg per Tablet

60mg per Tablet

Generic Nifedipine Controlled-release Tablets Segment by Application

Hypertension

Exertional Angina

Other

Generic Nifedipine Controlled-release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Generic Nifedipine Controlled-release Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Generic Nifedipine Controlled-release Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Generic Nifedipine Controlled-release Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Generic Nifedipine Controlled-release Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Nifedipine Controlled-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Generic Nifedipine Controlled-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Nifedipine Controlled-release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Generic Nifedipine Controlled-release Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Generic Nifedipine Controlled-release Tablets industry.

Chapter 3: Detailed analysis of Generic Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Generic Nifedipine Controlled-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Generic Nifedipine Controlled-release Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Generic Nifedipine Controlled-release Tablets Industry Trends Table 2. Generic Nifedipine Controlled-release Tablets Industry Drivers Table 3. Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges Table 4. Generic Nifedipine Controlled-release Tablets Industry Restraints Table 5. Global Generic Nifedipine Controlled-release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Generic Nifedipine Controlled-release Tablets Revenue Share by Company (2021-2026) Table 7. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Generic Nifedipine Controlled-release Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Generic Nifedipine Controlled-release Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Generic Nifedipine Controlled-release Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Generic Nifedipine Controlled-release Tablets Company, Product Type & Application Table 13. Global Generic Nifedipine Controlled-release Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Generic Nifedipine Controlled-release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 30mg per Tablet Table 18. Significant Companies of 60mg per Tablet Table 19. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Generic Nifedipine Controlled-release Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Generic Nifedipine Controlled-release Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Generic Nifedipine Controlled-release Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Type (2021-2026) Table 28. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hypertension Table 30. Significant Companies of Exertional Angina Table 31. Significant Companies of Other Table 32. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Generic Nifedipine Controlled-release Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Generic Nifedipine Controlled-release Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Generic Nifedipine Controlled-release Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Application (2021-2026) Table 41. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Application (2027-2032) Table 42. Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021-2026) Table 45. Global Generic Nifedipine Controlled-release Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2027-2032) Table 47. Global Generic Nifedipine Controlled-release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Generic Nifedipine Controlled-release Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Region (2021-2026) Table 50. Global Generic Nifedipine Controlled-release Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Region (2027-2032) Table 52. Global Generic Nifedipine Controlled-release Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Generic Nifedipine Controlled-release Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Generic Nifedipine Controlled-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Generic Nifedipine Controlled-release Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021-2026) Table 58. Global Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2027-2032) Table 60. Global Generic Nifedipine Controlled-release Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Generic Nifedipine Controlled-release Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Generic Nifedipine Controlled-release Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Generic Nifedipine Controlled-release Tablets Sales Value Market Share by Country (2027-2032) Table 64. Simcere Company Information Table 65. Simcere Business Overview Table 66. Simcere Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio Table 68. Simcere Recent Development Table 69. Shanghai Shyndec Pharma Company Information Table 70. Shanghai Shyndec Pharma Business Overview Table 71. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 73. Shanghai Shyndec Pharma Recent Development Table 74. Qingdao Baiyang Pharmaceutical Company Information Table 75. Qingdao Baiyang Pharmaceutical Business Overview Table 76. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio Table 78. Qingdao Baiyang Pharmaceutical Recent Development Table 79. Hefei Cube Pharma Company Information Table 80. Hefei Cube Pharma Business Overview Table 81. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 83. Hefei Cube Pharma Recent Development Table 84. Nanjing Easeheal Pharma Company Information Table 85. Nanjing Easeheal Pharma Business Overview Table 86. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 88. Nanjing Easeheal Pharma Recent Development Table 89. Deyao Pharma Company Information Table 90. Deyao Pharma Business Overview Table 91. Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 93. Deyao Pharma Recent Development Table 94. CR DOUBLE-CRANE Company Information Table 95. CR DOUBLE-CRANE Business Overview Table 96. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio Table 98. CR DOUBLE-CRANE Recent Development Table 99. Beijing Honglin Pharma Company Information Table 100. Beijing Honglin Pharma Business Overview Table 101. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 103. Beijing Honglin Pharma Recent Development Table 104. Apichope Company Information Table 105. Apichope Business Overview Table 106. Apichope Generic Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio Table 108. Apichope Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Generic Nifedipine Controlled-release Tablets Distributors List Table 112. Generic Nifedipine Controlled-release Tablets Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Generic Nifedipine Controlled-release Tablets Product Image Figure 2. Global Generic Nifedipine Controlled-release Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Generic Nifedipine Controlled-release Tablets Sales (2021-2032) & (K Units) Figure 5. Global Generic Nifedipine Controlled-release Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Generic Nifedipine Controlled-release Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 30mg per Tablet Image Figure 10. 60mg per Tablet Image Figure 11. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Generic Nifedipine Controlled-release Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Generic Nifedipine Controlled-release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Type (2021-2032) Figure 17. Hypertension Image Figure 18. Exertional Angina Image Figure 19. Other Image Figure 20. Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Generic Nifedipine Controlled-release Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Generic Nifedipine Controlled-release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Generic Nifedipine Controlled-release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Generic Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Generic Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Generic Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Generic Nifedipine Controlled-release Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Generic Nifedipine Controlled-release Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg per Tablet
  • 60mg per Tablet
Applications
  • Hypertension
  • Exertional Angina
  • Other
Companies covered
  • Simcere
  • Shanghai Shyndec Pharma
  • Qingdao Baiyang Pharmaceutical
  • Hefei Cube Pharma
  • Nanjing Easeheal Pharma
  • Deyao Pharma
  • CR DOUBLE-CRANE
  • Beijing Honglin Pharma
  • Apichope

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Generic Nifedipine Controlled-release Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Generic Nifedipine Controlled-release Tablets Market Dynamics
  1. 2.1 Generic Nifedipine Controlled-release Tablets Industry Trends
  2. 2.2 Generic Nifedipine Controlled-release Tablets Industry Drivers
  3. 2.3 Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges
  4. 2.4 Generic Nifedipine Controlled-release Tablets Industry Restraints
3 Generic Nifedipine Controlled-release Tablets Market by Company
  1. 3.1 Global Generic Nifedipine Controlled-release Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Generic Nifedipine Controlled-release Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Generic Nifedipine Controlled-release Tablets Company Ranking (2024-2026)
  6. 3.6 Global Generic Nifedipine Controlled-release Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Generic Nifedipine Controlled-release Tablets Company Product Type and Application
  8. 3.8 Global Generic Nifedipine Controlled-release Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Generic Nifedipine Controlled-release Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Generic Nifedipine Controlled-release Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Generic Nifedipine Controlled-release Tablets Market by Type
  1. 4.1 Generic Nifedipine Controlled-release Tablets Type Introduction
  2. 4.1.1 30mg per Tablet
  3. 4.1.2 60mg per Tablet
  4. 4.2 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type
  5. 4.2.1 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Generic Nifedipine Controlled-release Tablets Sales Value by Type
  9. 4.3.1 Global Generic Nifedipine Controlled-release Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Generic Nifedipine Controlled-release Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Type (2021-2032)
5 Generic Nifedipine Controlled-release Tablets Market by Application
  1. 5.1 Generic Nifedipine Controlled-release Tablets Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Exertional Angina
  4. 5.1.3 Other
  5. 5.2 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application
  6. 5.2.1 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Generic Nifedipine Controlled-release Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Generic Nifedipine Controlled-release Tablets Sales Value by Application
  10. 5.3.1 Global Generic Nifedipine Controlled-release Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Generic Nifedipine Controlled-release Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Generic Nifedipine Controlled-release Tablets Sales Value Share by Application (2021-2032)
6 Generic Nifedipine Controlled-release Tablets Regional Sales and Value Analysis
  1. 6.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region (2027-2032)
  5. 6.3 Global Generic Nifedipine Controlled-release Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Generic Nifedipine Controlled-release Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Generic Nifedipine Controlled-release Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Generic Nifedipine Controlled-release Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Generic Nifedipine Controlled-release Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Generic Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Generic Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Generic Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
7 Generic Nifedipine Controlled-release Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Generic Nifedipine Controlled-release Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Generic Nifedipine Controlled-release Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032)
  6. 7.4 Global Generic Nifedipine Controlled-release Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Generic Nifedipine Controlled-release Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Generic Nifedipine Controlled-release Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Generic Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Generic Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Generic Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Simcere
  2. 8.1.1 Simcere Company Information
  3. 8.1.2 Simcere Business Overview
  4. 8.1.3 Simcere Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio
  6. 8.1.5 Simcere Recent Developments
  7. 8.2 Shanghai Shyndec Pharma
  8. 8.2.1 Shanghai Shyndec Pharma Company Information
  9. 8.2.2 Shanghai Shyndec Pharma Business Overview
  10. 8.2.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  12. 8.2.5 Shanghai Shyndec Pharma Recent Developments
  13. 8.3 Qingdao Baiyang Pharmaceutical
  14. 8.3.1 Qingdao Baiyang Pharmaceutical Company Information
  15. 8.3.2 Qingdao Baiyang Pharmaceutical Business Overview
  16. 8.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio
  18. 8.3.5 Qingdao Baiyang Pharmaceutical Recent Developments
  19. 8.4 Hefei Cube Pharma
  20. 8.4.1 Hefei Cube Pharma Company Information
  21. 8.4.2 Hefei Cube Pharma Business Overview
  22. 8.4.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  24. 8.4.5 Hefei Cube Pharma Recent Developments
  25. 8.5 Nanjing Easeheal Pharma
  26. 8.5.1 Nanjing Easeheal Pharma Company Information
  27. 8.5.2 Nanjing Easeheal Pharma Business Overview
  28. 8.5.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  30. 8.5.5 Nanjing Easeheal Pharma Recent Developments
  31. 8.6 Deyao Pharma
  32. 8.6.1 Deyao Pharma Company Information
  33. 8.6.2 Deyao Pharma Business Overview
  34. 8.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  36. 8.6.5 Deyao Pharma Recent Developments
  37. 8.7 CR DOUBLE-CRANE
  38. 8.7.1 CR DOUBLE-CRANE Company Information
  39. 8.7.2 CR DOUBLE-CRANE Business Overview
  40. 8.7.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio
  42. 8.7.5 CR DOUBLE-CRANE Recent Developments
  43. 8.8 Beijing Honglin Pharma
  44. 8.8.1 Beijing Honglin Pharma Company Information
  45. 8.8.2 Beijing Honglin Pharma Business Overview
  46. 8.8.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  48. 8.8.5 Beijing Honglin Pharma Recent Developments
  49. 8.9 Apichope
  50. 8.9.1 Apichope Company Information
  51. 8.9.2 Apichope Business Overview
  52. 8.9.3 Apichope Generic Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio
  54. 8.9.5 Apichope Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Generic Nifedipine Controlled-release Tablets Value Chain Analysis
  2. 9.1.1 Generic Nifedipine Controlled-release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Generic Nifedipine Controlled-release Tablets Sales Mode & Process
  6. 9.2 Generic Nifedipine Controlled-release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Generic Nifedipine Controlled-release Tablets Distributors
  9. 9.2.3 Generic Nifedipine Controlled-release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst